Long-term control for > 9 years with megestrol acetate-letrozole: metastatic endometrioid carcinoma case report

20260 citationsJournal Articlegold Open Access

Authors

Abstract

This is the first case demonstrating that full-dose megestrol acetate plus letrozole may induce durable antitumor activity in HR-high expression metastatic EC, warranting prospective validation.

Topics & Keywords

Endometrial and Cervical Cancer Treatments Estrogen and related hormone effects Advanced Breast Cancer Therapies

Publication Details

Published in: Frontiers in Oncology

Volume 16, pp. 1729721-1729721

DOI: 10.3389/fonc.2026.1729721

Field-Weighted Citation Impact: 0.00

Command Palette

Long-term control for &gt; 9 years with megestrol acetate-letrozole: metastatic endometrioid carcinoma case report

Authors

Abstract

Topics & Keywords

Publication Details

Long-term control for > 9 years with megestrol acetate-letrozole: metastatic endometrioid carcinoma case report